LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2016 fiscal year (FY16) and fourth quarter (4Q16) ended August 31, 2016.
Results for the 2016 fiscal year (FY16):
• Revenues were $19.97 million, representing an increase of 9.1% over $18.31 million in FY15
